RNS Number : 8956Z Renalytix PLC 27 January 2022 Renalytix plc ("Renalytix" or the "Company") Grant of Share Options New York and SALT LAKE CITY , January 27, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that its Remuneration Committee has agreed to issue options over a total
RNS Number : 7789Z Renalytix PLC 27 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Present at BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference New York and SALT LAKE CITY , January 27, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today
RNS Number : 1056Y Renalytix PLC 11 January 2022 Renalytix plc ("Renalytix" or the "Company") Positive Study Results Published for KidneyIntelX TM in Monitoring Patient Response to New Drug Therapy American Journal of Nephrology data demonstrates KidneyIntelX successfully monitors patient
RNS Number : 8490X Renalytix PLC 10 January 2022 Renalytix plc ("Renalytix" or the "Company") Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved
RNS Number : 7098X Renalytix PLC 07 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix Appoints Jean M. Casner as Chief Human Resources Officer NEW YORK, NY and SALT LAKE CITY, UT January 7, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M.
RNS Number : 4318X Renalytix PLC 05 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Present at 40 th Annual J.P. Morgan Virtual Healthcare Conference LONDON and SALT LAKE CITY , January 5, 2022 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) today announced the Company
RNS Number : 2538X Renalytix PLC 04 January 2022 Renalytix plc ("Renalytix" or the "Company") American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population National program establishes early care management, technology innovation and large
RNS Number : 0925W Renalytix PLC 17 December 2021 Renalytix plc (" Renalytix " or the " Company ") Result of AGM LONDON and SALT LAKE , 17 December 2021 - Renalytix (NASDAQ: RNLX) (LSE: RENX) announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were
RNS Number : 0593W Renalytix PLC 17 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 17 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by Ann Berman , the Company's Non-Executive Director, of 3,000
RNS Number : 3617V Renalytix PLC 13 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 13 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of